EGFR and breast neoplasm: Consistent with a potential role for EGFR in HER2Δ16 tumorigenesis, coexpression of EGFR in breast tumors with activated HER2 is associated with significantly shorter patient survival than patients with tumor expression of activated HER2 or EGFR alone [31].